Low level of polymyxin resistance among nonclonal mcr-1–positive Escherichia coli from human sources in Brazil
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 93 (2) , 140-142
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trialThe Lancet Infectious Diseases, 2018
- Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant EnterobacteriaceaeClinical Infectious Diseases, 2017
- Co-occurrence of mcr-1 and blaKPC-2 in a clinical isolate of Escherichia coli in BrazilJournal of Antimicrobial Chemotherapy, 2017
- First Report of the Globally Disseminated IncX4 Plasmid Carrying the mcr-1 Gene in a Colistin-Resistant Escherichia coli Sequence Type 101 Isolate from a Human Infection in BrazilAntimicrobial Agents and Chemotherapy, 2016
- Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015Antimicrobial Agents and Chemotherapy, 2016
- Real-time quantitative PCR assay with Taqman ® probe for rapid detection of MCR-1 plasmid-mediated colistin resistanceNew Microbes and New Infections, 2016
- Silent dissemination of colistin-resistant Escherichia coli in South America could contribute to the global spread of the mcr-1 geneEurosurveillance, 2016
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studyThe Lancet Infectious Diseases, 2016
- Evaluation of the DiversiLab System for Detection of Hospital Outbreaks of Infections by Different Bacterial SpeciesJournal of Clinical Microbiology, 2010